176
Participants
Start Date
January 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
BMS747158
"dosages at rest and at stress were not to exceed a total of 14 mCi.~Cohort 1: Patients received either 2 or 3 IV bolus injections of BMS747158: 1 at rest and 1 or 2 during stress, over a 1-day or 2-day period.~Cohort 2: Patients to recieve IV bolus injections of BMS747158:~For the Pharmacologic (Adenosine) Stress:~* Doses at rest were to range between 2.9 and 3.4 mCi.~* Doses under stress were to be a factor of 2.0 to 2.4 greater than the rest dose, resulting in a range of stress doses between 5.8 and 8.2 mCi.~For the Exercise Stress:~* Doses at rest were to range between 1.7 and 2.0 mCi.~* Doses under stress were to be a factor of 3.0 to 3.6 greater than the rest dose, resulting in a range between 5.1 and 7.2 mCi."
Columbia University Medical Center, New York
St. Francis Hospital, Roslyn
East Tennessee Clinical Research Institute, Knoxville
Emory University Hospital, Atlanta
Mountain States Health Alliance, Johnson City
Midwest Cardiology Research Foundation, Columbus
University Hospital Case Medical Center, Cleveland
University of Michigan, Ann Arbor
Saint Louis University, St Louis
Washington University School of Medicine, St Louis
Cardiovascular Consultants, Kansas City
Cedars-Sinai Medical Center, Los Angeles
UCLA Medical Plaza, Los Angeles
Scripps Memorial Hospital, La Jolla
VA Healthcare System San Diego, San Diego
Silicon Valley Medical Imaging, Fremont
Radiological Associates of Sacramento, Sacramento
Hartford Hospital, Hartford
Yale University, New Haven
Primary Care Cardiology Research, Inc, Ayer
Massachusetts General Hospital, Boston
Brigham & Women's Hospital, Boston
University of Medicine and Dentistry of New Jersey, Newark
Holy Name Hospital, Teaneck
Lead Sponsor
Lantheus Medical Imaging
INDUSTRY